We are live on ! Find out more
OM icon

Outset Medical

78 hedge funds and large institutions have $17.6M invested in Outset Medical in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 36 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more call options, than puts

Call options by funds: $57K | Put options by funds: $56K

2.93% less ownership

Funds ownership: 6.26%3.33% (-2.9%)

36% less funds holding

Funds holding: 12278 (-44)

56% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 36

88% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 50

91% less capital invested

Capital invested by funds: $187M → $17.6M (-$169M)

Holders
78
Holders Change
-44
Holders Change %
-36.07%
% of All Funds
1.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
16
Reduced
36
Closed
50
Calls
$57K
Puts
$56K
Net Calls
+$1K
Net Calls Change
-$361K
Name Holding Trade Value Shares
Change
Change in
Stake
BTI
76
Blue Trust Inc
Georgia
$15 -$1.01K -34 Closed
FCA
77
FinTrust Capital Advisors
South Carolina
$14 -$1.19K -40 -98%
Wells Fargo
78
Wells Fargo
California
$7
CWM
79
Cranbrook Wealth Management
Michigan
$5
Massachusetts Financial Services
80
Massachusetts Financial Services
Massachusetts
-$5.92M -102,591 Closed
BG
81
Bellevue Group
Switzerland
-$2.94M -50,853 Closed
PHS
82
PFM Health Sciences
California
-$2.87M -49,640 Closed
B
83
Braidwell
Connecticut
-$2.67M -46,302 Closed
Bank of New York Mellon
84
Bank of New York Mellon
New York
-$1.91M -33,025 Closed
Lazard Asset Management
85
Lazard Asset Management
New York
-$1.81M -31,313 Closed
Norges Bank
86
Norges Bank
Norway
-$1.78M -30,760 Closed
Charles Schwab
87
Charles Schwab
California
-$1.14M -19,681 Closed
Point72 Asset Management
88
Point72 Asset Management
Connecticut
-$827K -14,327 Closed
Walleye Capital
89
Walleye Capital
New York
-$799K -13,832 Closed
SPS
90
Susquehanna Portfolio Strategies
Pennsylvania
-$788K -13,648 Closed
CSS
91
Cubist Systematic Strategies
Connecticut
-$774K -13,396 Closed
Los Angeles Capital Management
92
Los Angeles Capital Management
California
-$731K -12,652 Closed
PP
93
PDT Partners
New York
-$556K -9,630 Closed
AQR Capital Management
94
AQR Capital Management
Connecticut
-$548K -9,495 Closed
Dimensional Fund Advisors
95
Dimensional Fund Advisors
Texas
-$548K -9,486 Closed
HF
96
HRT Financial
New York
-$531K -9,205 Closed
YIH
97
Y-Intercept (HK)
Hong Kong
-$489K -8,472 Closed
Squarepoint
98
Squarepoint
New York
-$309K -5,353 Closed
Verition Fund Management
99
Verition Fund Management
Connecticut
-$283K -4,905 Closed
PP
100
Paloma Partners
Connecticut
-$220K -3,810 Closed

OM Hedge Fund Activity: Q3 2024 in Review

78 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2024, worth a combined $17.6M — down 91% from $187M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of OM and 6 opened new positions — a net loss of 44 holders — while 36 trimmed existing stakes and 16 added.

The largest buyer was GSA Capital Partners, adding an estimated $1.99M. The largest seller was Ameriprise, cutting an estimated $6.72M.

  • 78 institutional investors held Outset Medical (OM) as of Q3 2024, down from 122 in Q2 2024.
  • Funds reported $17.6M of Outset Medical stock for Q3 2024, down 91% quarter-over-quarter.
  • 6 funds opened new Outset Medical positions in Q3 2024 and 50 closed out, a net change of -44 holders.
  • The largest Outset Medical buyer in Q3 2024 was GSA Capital Partners, an estimated $1.99M added.
  • The largest Outset Medical seller in Q3 2024 was Ameriprise, an estimated $6.72M sold.

Based on aggregated 13F filings for Q3 2024.